the clinical efficacy and the safety of ciprofloxacin was studied in 92 patients ( aged 26 to 83 years ; mean 57.5 years ) affected by urinary tract infections ( uti ) and respiratory tract infections ( rti ) suffering also with various liver diseases .
C0008809
ciprofloxacin
C0042029
urinary tract infections